Supreme Court Stay Keeps Medication Abortion Options Open for Now

Want the full story?
Read the complete article at KVIA
AI Summary
Recent legal developments have left the future of medication abortion in a state of uncertainty. The U.S. Supreme Court issued a stay that temporarily maintains access to mifepristone, a key drug in medication abortions, allowing for its prescription via telehealth and mail until the court reviews appeals next week. Should access be restricted, patients can still utilize misoprostol alone, which remains a safe and effective alternative. This situation affects many individuals seeking abortion services, particularly in states with strict laws. As the legal landscape evolves, those in need of abortion care should stay informed about their options and consult healthcare providers for guidance.
Key Details: • Supreme Court stay on mifepristone access remains until next week. • Patients may need to consider misoprostol alone if mifepristone access is restricted. • Misoprostol is considered safe and effective, with a success rate of about 90%.